
Ratings Moves: HVB,...


| Price and Volume | |
|---|---|
| Recent Price | 4.58 |
| 52 Week High | 5.80 |
| 52 Week Low | 3.61 |
| Avg. Daily Vol. (Mil) | 0.03 |
| Beta (3 year) | 0.18 |
| Share Related Items | |
| Mkt Cap (Mil) | 42.52 |
| Shares Out (Mil) | 9.29 |
| Float (Mil) | 7.06 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 2.50 |
| Current Ratio | 3.50 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | 45.80 |
| Price/Sales | 1.66 |
| Price/Book | 2.98 |
| Price/Cash Flow | 23.70 |
| Per Share Data | |
| Earnings | 0.10 |
| Sales | 2.76 |
| Book Value | 1.54 |
| Cash Flow | 0.19 |
| Business Summary | |
|---|---|
| Chembio Diagnostics, Inc. with its subsidiaries develops, manufacture and market diagnostic tests that detect infectious diseases. | |
| General Information | |
| 3661 Horseblock Road
Medford, NY 11763 |
|
| www.chembio.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 174 | |
| CEO: Lawrence A. Siebert | |
| Short Interest | |
| Current Month (Mil) | 0.03 |
| Previous Month (Mil) | 0.01 |
| Short Interest Ratio (Days) | 0.70 |
| Management Effectiveness | |
| Return on Equity | 8.80 |
| Return on Assets | 7.20 |
| Return on Investments | 8.80 |
| Profitability | |
| Gross Margin | 41.70 |
| EBIT Margin | 4.80 |
| Profit Margin | 4.90 |